Semaglutide Oral Formulation Reduces Cardiovascular Risk in Type 2 Diabetes Patients

A new phase 3b trial found that the oral formulation of semaglutide, a GLP-1 receptor agonist, reduces the risk for major adverse cardiovascular events in patients with type 2 diabetes and established atherosclerotic cardiovascular disease or chronic kidney disease. The study, SOUL, involved over 9,650 patients and showed a 14% relative reduction in cardiovascular death, … Read more

Tesla Takedown Protests Grow as Critics Target Musk’s Job Cuts

Protesters in Berkeley, California, gathered in front of a Tesla dealership on Saturday, joining thousands of others worldwide in condemning Elon Musk’s efforts to scale down the federal workforce. The “Tesla Takedown” protests have been growing since their inception last month, with over 1,000 demonstrators attending the latest event. Critics argue that Musk is using … Read more

Kim Delaney Arrested on Felony Assault Charges

Actress Kim Delaney, known for her role in NYPD Blue, was arrested on Saturday after an alleged domestic disturbance with her partner James Morgan. The Los Angeles County Sheriff’s Department took her into custody at 10:15am after a heated altercation turned physical. Delaney faces felony assault with a deadly weapon charges, while Morgan received a … Read more

Website Overwhelmed with Excessive Requests

A website has reached its maximum capacity due to an overwhelming number of requests. This issue is often referred to as a “rate limiting” problem. When a website receives too many requests in a short period, it may become unresponsive or even crash. This can be caused by various factors such as a surge in … Read more

Overlapping Meteor Showers to Hit Sky in April

Stargazers will witness two overlapping meteor showers in April, providing a unique opportunity to see multiple shooting stars in the night sky. The Lyrids meteor shower begins on April 17 and peaks on April 22, while the Eta Aquarids meteor shower starts on April 20 and runs until May 21. During this overlap, stargazers can … Read more

Canada Cuts US Travel Amid Tensions Over Trump Policies

Canada’s travel industry is reeling as Canadians cut their trips to the United States, threatening to widen the country’s $50 billion travel deficit. The decline in trans-border travel is attributed to various factors, including an unfavorable currency exchange rate and the U.S.’s complex immigration policies under President Donald Trump. Experts say that Canada’s decision to … Read more

Marine Le Pen’s Presidential Bid at Risk Over EU Fund Scandal

French Court Weighs Ban on Marine Le Pen Due to EU Fund Misuse Allegations Marine Le Pen, leader of the National Rally party, faces a critical court ruling on Monday that could determine her eligibility to run for president in 2027. The Paris judges will decide whether she and her party are guilty of diverting … Read more

Nvidia Fails to Fix Black Screen Issues on Older RTX Cards

Nvidia has released several hotfixes and driver updates aimed at fixing black screen issues affecting some of its new RTX-50 cards. However, gamers with older RTX 40 and 30-series cards are facing worse problems than ever. Since the release of the RTX 5090 in January, Nvidia’s graphics cards have experienced numerous black screen crashes and … Read more

‘SNL’ Mocks Pentagon Chief with Savage Jabs Amid Leaked Chat Scandal

“Saturday Night Live” (SNL) has ignited backlash after a recent cold open targeting Secretary of Defense Pete Hegseth, with many viewers labeling the show’s “Weekend Update” segment as a “blatant hit job.” The controversy centers around Colin Jost’s jabs at Hegseth during the live broadcast. The SNL sketch pokes fun at a real-life group chat … Read more

New Trial Data Suggests Promising Leptodisiran Therapy for Elevated Lipoprotein(a)

A phase 2 trial known as ALPACA has shown that lepodisiran, a long-acting small interfering RNA therapy, can significantly reduce lipoprotein(a) [Lp(a)] levels in patients with elevated Lp(a]. The results were presented at the American College of Cardiology (ACC) 2025 Annual Scientific Sessions. The trial found that patients receiving lepodisiran achieved reductions of 40.8%, 75.2%, … Read more